182 related articles for article (PubMed ID: 9494108)
1. Heparin accelerates the inhibition of cathepsin G by mucus proteinase inhibitor: potent effect of O-butyrylated heparin.
Ermolieff J; Duranton J; Petitou M; Bieth JG
Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1369-74. PubMed ID: 9494108
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin.
Boudier C; Cadène M; Bieth JG
Biochemistry; 1999 Jun; 38(26):8451-7. PubMed ID: 10387091
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin.
Walter M; Plotnick M; Schechter NM
Arch Biochem Biophys; 1996 Mar; 327(1):81-8. PubMed ID: 8615699
[TBL] [Abstract][Full Text] [Related]
4. Heparin protects cathepsin G against inhibition by protein proteinase inhibitors.
Ermolieff J; Boudier C; Laine A; Meyer B; Bieth JG
J Biol Chem; 1994 Nov; 269(47):29502-8. PubMed ID: 7961933
[TBL] [Abstract][Full Text] [Related]
5. The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites.
Cooley J; Takayama TK; Shapiro SD; Schechter NM; Remold-O'Donnell E
Biochemistry; 2001 Dec; 40(51):15762-70. PubMed ID: 11747453
[TBL] [Abstract][Full Text] [Related]
6. The location of inhibitory specificities in human mucus proteinase inhibitor (MPI): separate expression of the COOH-terminal domain yields an active inhibitor of three different proteinases.
Meckelein B; Nikiforov T; Clemen A; Appelhans H
Protein Eng; 1990 Jan; 3(3):215-20. PubMed ID: 2158659
[TBL] [Abstract][Full Text] [Related]
7. The proteinase: mucus proteinase inhibitor binding stoichiometry.
Boudier C; Bieth JG
J Biol Chem; 1992 Mar; 267(7):4370-5. PubMed ID: 1537827
[TBL] [Abstract][Full Text] [Related]
8. Heparin-induced conformational change and activation of mucus proteinase inhibitor.
Faller B; Mely Y; Gerard D; Bieth JG
Biochemistry; 1992 Sep; 31(35):8285-90. PubMed ID: 1525165
[TBL] [Abstract][Full Text] [Related]
9. Influence of low molecular mass heparin on the kinetics of neutrophil elastase inhibition by mucus proteinase inhibitor.
Cadène M; Boudier C; de Marcillac GD; Bieth JG
J Biol Chem; 1995 Jun; 270(22):13204-9. PubMed ID: 7768918
[TBL] [Abstract][Full Text] [Related]
10. Mapping the heparin-binding site of mucus proteinase inhibitor.
Mellet P; Ermolieff J; Bieth JG
Biochemistry; 1995 Feb; 34(8):2645-52. PubMed ID: 7873546
[TBL] [Abstract][Full Text] [Related]
11. Heparin strongly decreases the rate of inhibition of neutrophil elastase by alpha 1-proteinase inhibitor.
Frommherz KJ; Faller B; Bieth JG
J Biol Chem; 1991 Aug; 266(23):15356-62. PubMed ID: 1869557
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of serine proteases: activity of 1,3-diazetidine-2,4-diones.
Aoyama Y; Uenaka M; Konoike T; Hayasaki-Kajiwara Y; Naya N; Nakajima M
Bioorg Med Chem Lett; 2001 Jul; 11(13):1691-4. PubMed ID: 11425539
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the human leukocyte endopeptidases elastase and cathepsin G and of porcine pancreatic elastase by N-oleoyl derivatives of heparin.
Baici A; Diczházi C; Neszmélyi A; Móczár E; Hornebeck W
Biochem Pharmacol; 1993 Nov; 46(9):1545-9. PubMed ID: 8240409
[TBL] [Abstract][Full Text] [Related]
14. DNA strongly impairs the inhibition of cathepsin G by alpha(1)-antichymotrypsin and alpha(1)-proteinase inhibitor.
Duranton J; Boudier C; Belorgey D; Mellet P; Bieth JG
J Biol Chem; 2000 Feb; 275(6):3787-92. PubMed ID: 10660528
[TBL] [Abstract][Full Text] [Related]
15. Effect of polynucleotides on the inhibition of neutrophil elastase by mucus proteinase inhibitor and alpha 1-proteinase inhibitor.
Belorgey D; Bieth JG
Biochemistry; 1998 Nov; 37(46):16416-22. PubMed ID: 9819234
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of a trihexacontapeptide corresponding to the sequence 8-70 of eglin c and studies on the relationship between the structure and the inhibitory activity against human leukocyte elastase, cathepsin G and alpha-chymotrypsin.
Okada Y; Tsuboi S; Tsuda Y; Nagamatsu Y; Yamamoto J
FEBS Lett; 1990 Oct; 272(1-2):113-6. PubMed ID: 2226822
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of neutrophil elastase by the alpha1-proteinase inhibitor-immunoglobulin A complex.
Adam C; Bieth JG
FEBS Lett; 1996 May; 385(3):201-4. PubMed ID: 8647251
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II generation at the cell surface of activated neutrophils: novel cathepsin G-mediated catalytic activity that is resistant to inhibition.
Owen CA; Campbell EJ
J Immunol; 1998 Feb; 160(3):1436-43. PubMed ID: 9570564
[TBL] [Abstract][Full Text] [Related]
19. Interference of recombinant eglin C, a proteinase inhibitor extracted from leeches, with neutrophil-mediated platelet activation.
Renesto P; Ferrer-Lopez P; Chignard M
Lab Invest; 1990 Apr; 62(4):409-16. PubMed ID: 2159081
[TBL] [Abstract][Full Text] [Related]
20. Mutants of plasminogen activator inhibitor-1 designed to inhibit neutrophil elastase and cathepsin G are more effective in vivo than their endogenous inhibitors.
Stefansson S; Yepes M; Gorlatova N; Day DE; Moore EG; Zabaleta A; McMahon GA; Lawrence DA
J Biol Chem; 2004 Jul; 279(29):29981-7. PubMed ID: 15131125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
